MoneyWorks4Me

Bharat Immunologicals & Biologicals Corporation submits limited review report

13 Aug 2019 Evaluate

In pursuance of Regulation 33(3)(C) of the LODR with Stock Exchange, Bharat Immunologicals & Biologicals Corporation has informed about submission of the Limited Review Report along with the financial results for the Quarter ended 30th June 2019. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..